Lilly Jumps 3.64% While a $100 Billion Obesity Race Crowds In

Eli Lilly NYSE:LLY, the obesity and diabetes drugmaker, faces a growing field of challengers chasing a weight loss market that could reach $100 billion in annual sales. Shares rose about 3.6% to $1,192.91 at 10.51am ET Time on Thursday morning, measured against Wednesday's $1,150.99 close.Lilly has…